Abstract C255: Discovery of TAK-632: A Selective Kinase Inhibitor of Pan-Raf with Potent Antitumor Activity Against BRAF and NRAS Mutant Melanomas.
Molecular cancer therapeutics(2013)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Molecular cancer therapeutics(2013)